Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands |
3 Months Ended |
9 Months Ended |
Sep. 30, 2015 |
Sep. 30, 2014 |
Sep. 30, 2015 |
Sep. 30, 2014 |
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
$ (48,482)
|
$ 12,877
|
$ (58,638)
|
$ 16,322
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
39,584
|
36,149
|
118,474
|
106,666
|
| Accretion Expense |
|
|
547
|
0
|
| Other Asset Impairment Charges |
906
|
0
|
3,222
|
0
|
| Loss on extinguishment of debt |
0
|
0
|
0
|
(30,152)
|
| (Gain) loss on disposition of assets |
(383)
|
457
|
(2,686)
|
(433)
|
| Deferred income tax benefit |
|
|
10,259
|
(73)
|
| Expenses not requiring cash |
|
|
8,029
|
10,141
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
51,254
|
(5,188)
|
| Accrued income taxes |
|
|
(7,305)
|
(10,397)
|
| Other assets |
|
|
1,486
|
7,554
|
| Accounts payable and accrued liabilities |
|
|
(15,790)
|
(10,539)
|
| Net cash provided by operating activities |
|
|
108,852
|
144,351
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(72,469)
|
(151,109)
|
| Proceeds from the sale of assets |
|
|
731
|
2,294
|
| Proceeds from insurance settlements |
|
|
2,500
|
0
|
| Net cash (used in) investing activities |
|
|
(79,669)
|
(148,815)
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
400,000
|
| Repayments of long-term debt |
|
|
|
(432,500)
|
| Paydown on term note |
|
|
(30,000)
|
(432,500)
|
| Payment of debt issuance costs |
|
|
(1,996)
|
(7,630)
|
| Payments of debt extinguishment costs |
|
|
0
|
(26,214)
|
| Excess tax benefit from stock-based compensation |
|
|
(992)
|
430
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash (used in) financing activities |
|
|
(32,988)
|
(65,914)
|
| Net (decrease) in cash and cash equivalents |
|
|
(3,805)
|
(70,378)
|
| Cash and cash equivalents, beginning of year |
|
|
108,456
|
148,689
|
| Cash and cash equivalents, end of period |
104,651
|
78,311
|
104,651
|
78,311
|
| Parent [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(48,620)
|
12,566
|
(59,427)
|
15,698
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion Expense |
|
|
0
|
|
| Other Asset Impairment Charges |
0
|
|
0
|
|
| Loss on extinguishment of debt |
|
|
|
(30,152)
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
79
|
| Deferred income tax benefit |
|
|
24,184
|
15,774
|
| Expenses not requiring cash |
|
|
6,498
|
9,940
|
| Equity in net earnings of subsidiaries |
29,913
|
(19,442)
|
29,316
|
(50,591)
|
| Accounts and notes receivable |
|
|
(33)
|
0
|
| Accrued income taxes |
|
|
6,481
|
(13,232)
|
| Other assets |
|
|
(121,465)
|
43,412
|
| Accounts payable and accrued liabilities |
|
|
(10,480)
|
(8,213)
|
| Net cash provided by operating activities |
|
|
(173,294)
|
11,471
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Proceeds from insurance settlements |
|
|
0
|
|
| Net cash (used in) investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
400,000
|
| Repayments of long-term debt |
|
|
|
(432,500)
|
| Paydown on term note |
|
|
(30,000)
|
|
| Payment of debt issuance costs |
|
|
(1,996)
|
(7,630)
|
| Payments of debt extinguishment costs |
|
|
|
26,214
|
| Excess tax benefit from stock-based compensation |
|
|
(992)
|
430
|
| Intercompany advances, net |
|
|
216,082
|
(10,677)
|
| Net cash (used in) financing activities |
|
|
183,094
|
(76,591)
|
| Net (decrease) in cash and cash equivalents |
|
|
9,800
|
(65,120)
|
| Cash and cash equivalents, beginning of year |
|
|
36,728
|
88,697
|
| Cash and cash equivalents, end of period |
46,528
|
23,577
|
46,528
|
23,577
|
| Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(4,119)
|
19,980
|
(8,984)
|
54,169
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
24,002
|
22,168
|
71,270
|
63,343
|
| Accretion Expense |
|
|
0
|
|
| Other Asset Impairment Charges |
920
|
|
920
|
|
| Loss on extinguishment of debt |
|
|
|
0
|
| (Gain) loss on disposition of assets |
(407)
|
(91)
|
(452)
|
(522)
|
| Deferred income tax benefit |
|
|
(10,032)
|
(12,525)
|
| Expenses not requiring cash |
|
|
2,677
|
(1,538)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
36,694
|
(1,715)
|
| Accrued income taxes |
|
|
(2,081)
|
11,764
|
| Other assets |
|
|
110,017
|
(58,441)
|
| Accounts payable and accrued liabilities |
|
|
(168)
|
(9,395)
|
| Net cash provided by operating activities |
|
|
219,925
|
70,190
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(50,396)
|
(107,137)
|
| Proceeds from the sale of assets |
|
|
489
|
1,088
|
| Proceeds from insurance settlements |
|
|
0
|
|
| Net cash (used in) investing activities |
|
|
(60,338)
|
(106,049)
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
0
|
| Repayments of long-term debt |
|
|
|
0
|
| Paydown on term note |
|
|
0
|
|
| Payment of debt issuance costs |
|
|
0
|
0
|
| Payments of debt extinguishment costs |
|
|
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
| Intercompany advances, net |
|
|
(165,133)
|
40,064
|
| Net cash (used in) financing activities |
|
|
(165,133)
|
40,064
|
| Net (decrease) in cash and cash equivalents |
|
|
(5,546)
|
4,205
|
| Cash and cash equivalents, beginning of year |
|
|
13,546
|
8,310
|
| Cash and cash equivalents, end of period |
8,000
|
12,515
|
8,000
|
12,515
|
| Non-Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(25,656)
|
(227)
|
(19,543)
|
(2,954)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
15,582
|
13,981
|
47,204
|
43,323
|
| Accretion Expense |
|
|
547
|
|
| Other Asset Impairment Charges |
(14)
|
|
2,302
|
|
| Loss on extinguishment of debt |
|
|
|
0
|
| (Gain) loss on disposition of assets |
24
|
548
|
(2,234)
|
10
|
| Deferred income tax benefit |
|
|
(24,411)
|
(3,322)
|
| Expenses not requiring cash |
|
|
(1,146)
|
1,739
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
14,593
|
(3,473)
|
| Accrued income taxes |
|
|
(11,705)
|
(8,929)
|
| Other assets |
|
|
12,934
|
22,583
|
| Accounts payable and accrued liabilities |
|
|
(5,142)
|
7,069
|
| Net cash provided by operating activities |
|
|
62,221
|
62,690
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(22,073)
|
(43,972)
|
| Proceeds from the sale of assets |
|
|
242
|
1,206
|
| Proceeds from insurance settlements |
|
|
2,500
|
|
| Net cash (used in) investing activities |
|
|
(19,331)
|
(42,766)
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
0
|
| Repayments of long-term debt |
|
|
|
0
|
| Paydown on term note |
|
|
0
|
|
| Payment of debt issuance costs |
|
|
0
|
0
|
| Payments of debt extinguishment costs |
|
|
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
| Intercompany advances, net |
|
|
(50,949)
|
(29,387)
|
| Net cash (used in) financing activities |
|
|
(50,949)
|
(29,387)
|
| Net (decrease) in cash and cash equivalents |
|
|
(8,059)
|
(9,463)
|
| Cash and cash equivalents, beginning of year |
|
|
58,182
|
51,682
|
| Cash and cash equivalents, end of period |
50,123
|
42,219
|
50,123
|
42,219
|
| Eliminations [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
29,913
|
(19,442)
|
29,316
|
(50,591)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion Expense |
|
|
0
|
|
| Other Asset Impairment Charges |
0
|
|
0
|
|
| Loss on extinguishment of debt |
|
|
|
0
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
| Deferred income tax benefit |
|
|
0
|
0
|
| Expenses not requiring cash |
|
|
0
|
0
|
| Equity in net earnings of subsidiaries |
(29,913)
|
19,442
|
(29,316)
|
50,591
|
| Accounts and notes receivable |
|
|
0
|
0
|
| Accrued income taxes |
|
|
0
|
0
|
| Other assets |
|
|
0
|
0
|
| Accounts payable and accrued liabilities |
|
|
0
|
0
|
| Net cash provided by operating activities |
|
|
0
|
0
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Proceeds from insurance settlements |
|
|
0
|
|
| Net cash (used in) investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from debt issuance |
|
|
|
0
|
| Repayments of long-term debt |
|
|
|
0
|
| Paydown on term note |
|
|
0
|
|
| Payment of debt issuance costs |
|
|
0
|
0
|
| Payments of debt extinguishment costs |
|
|
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash (used in) financing activities |
|
|
0
|
0
|
| Net (decrease) in cash and cash equivalents |
|
|
0
|
0
|
| Cash and cash equivalents, beginning of year |
|
|
0
|
0
|
| Cash and cash equivalents, end of period |
$ 0
|
$ 0
|
$ 0
|
$ 0
|